Schedule 13D ownership disclosure

AnPac Bio-Medical Science Co., Ltd.

Security class unavailable · CUSIP: G0393E107

Event date: 2022-02-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
365,961
Percent of class
2.6900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-022669
Form type
SC 13D/A
Filer
Fresh2 Group Ltd
CIK
CIK 1786511
Filed
Feb 14, 2022
Reporting period
Feb 14, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub